National Institutes of Health
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) is a funding opportunity from National Institutes of Health, closing December 23, 2027.
Dec 23, 2027
(510d left)